Tounjian Advisory Partners LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tounjian Advisory Partners LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 10,402 shares of the medical equipment provider's stock, valued at approximately $5,152,000. Intuitive Surgical accounts for about 0.9% of Tounjian Advisory Partners LLC's holdings, making the stock its 27th largest position.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Brighton Jones LLC grew its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $6,509,000. Vest Financial LLC increased its stake in shares of Intuitive Surgical by 22.1% in the fourth quarter. Vest Financial LLC now owns 2,725 shares of the medical equipment provider's stock worth $1,422,000 after buying an additional 493 shares during the last quarter. Kingsview Wealth Management LLC boosted its stake in Intuitive Surgical by 2.2% during the 4th quarter. Kingsview Wealth Management LLC now owns 4,354 shares of the medical equipment provider's stock valued at $2,273,000 after acquiring an additional 94 shares during the last quarter. Finally, Empowered Funds LLC raised its stake in shares of Intuitive Surgical by 181.4% in the 4th quarter. Empowered Funds LLC now owns 23,006 shares of the medical equipment provider's stock valued at $12,008,000 after purchasing an additional 14,829 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 215 shares of Intuitive Surgical stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $549.06, for a total transaction of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at approximately $970,738.08. The trade was a 10.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 25,443 shares of company stock worth $12,692,195. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 0.2%

ISRG stock opened at $557.08 on Monday. The company has a market capitalization of $199.67 billion, a P/E ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. The company has a 50-day simple moving average of $521.99 and a 200 day simple moving average of $539.16. Intuitive Surgical, Inc. has a fifty-two week low of $413.52 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of several research analyst reports. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Finally, Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.